Zydus Makes $125M Entry into Biologics with Acquisitions In a strategic move set to reshape its future growth trajectory, Zydus Lifesciences Ltd has officially entered the biologics space by acquiring assets worth $125 million, signaling its transition toward high-value, innovation-driven … Continue reading Zydus Makes $125M Entry into Biologics with Acquisitions